• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Reverse J-Shaped Association Between Serum Total 25-Hydroxyvitamin D Concentration and All-Cause Mortality: The Impact of Assay Standardization.血清总25-羟基维生素D浓度与全因死亡率之间的反向J形关联:检测标准化的影响。
Am J Epidemiol. 2017 Apr 15;185(8):720-726. doi: 10.1093/aje/kww244.
2
Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.美国老年成年人血清25-羟维生素D水平、心血管疾病死亡率和全因死亡率的前瞻性研究。
J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. Epub 2009 Jun 22.
3
Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES.25-羟维生素 D 与全因死亡率之间是否存在反向 J 型关联?来自美国具有全国代表性的 NHANES 的结果。
J Clin Endocrinol Metab. 2013 Jul;98(7):3001-9. doi: 10.1210/jc.2013-1333. Epub 2013 May 10.
4
Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys.评估维生素 D 标准化计划方案用于标准化血清 25-羟维生素 D 数据的效果:以该方案应用于国家营养与健康调查为例。
Am J Clin Nutr. 2013 Jun;97(6):1235-42. doi: 10.3945/ajcn.112.057182. Epub 2013 Apr 24.
5
Lifetime risk of cardiometabolic mortality according to vitamin D status of middle and older-aged adults: NHANES III mortality follow-up.根据中老年人维生素 D 状况评估心血管代谢性死亡率的终生风险:NHANES III 死亡率随访研究。
J Steroid Biochem Mol Biol. 2019 Feb;186:34-41. doi: 10.1016/j.jsbmb.2018.09.007. Epub 2018 Sep 13.
6
Vitamin D measurement standardization: The way out of the chaos.维生素D测量标准化:摆脱混乱的途径。
J Steroid Biochem Mol Biol. 2017 Oct;173:117-121. doi: 10.1016/j.jsbmb.2016.12.002. Epub 2016 Dec 12.
7
Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006).血清 25-羟维生素 D 与 NHANES III 研究(1988-2006 年)中的癌症死亡率。
Cancer Res. 2010 Nov 1;70(21):8587-97. doi: 10.1158/0008-5472.CAN-10-1420. Epub 2010 Sep 16.
8
Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium.维生素D与死亡率:对来自一个欧洲联盟的26916名个体的标准化25-羟基维生素D进行的个体参与者数据荟萃分析。
PLoS One. 2017 Feb 16;12(2):e0170791. doi: 10.1371/journal.pone.0170791. eCollection 2017.
9
A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study.血清25-羟基维生素D与心血管疾病死亡率之间的反向J形关联:慢性阻塞性肺疾病(CopD)研究
J Clin Endocrinol Metab. 2015 Jun;100(6):2339-46. doi: 10.1210/jc.2014-4551. Epub 2015 Feb 24.
10
Standardizing serum 25-hydroxyvitamin D data from four Nordic population samples using the Vitamin D Standardization Program protocols: Shedding new light on vitamin D status in Nordic individuals.使用维生素D标准化计划方案对来自四个北欧人群样本的血清25-羟基维生素D数据进行标准化:为北欧个体的维生素D状况提供新线索。
Scand J Clin Lab Invest. 2015 Nov;75(7):549-61. doi: 10.3109/00365513.2015.1057898.

引用本文的文献

1
Predictive effects of advanced lung cancer inflammation index and serum vitamin D on mortality in patients with asthma.晚期肺癌炎症指数和血清维生素D对哮喘患者死亡率的预测作用
Nutr J. 2025 Feb 15;24(1):26. doi: 10.1186/s12937-024-01065-6.
2
Unveiling the Interplay-Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2.揭示维生素D与血管紧张素转换酶2(ACE-2)的分子相互作用在减轻新冠病毒(SARS-CoV-2)并发症和死亡方面的作用
Biology (Basel). 2024 Oct 16;13(10):831. doi: 10.3390/biology13100831.
3
Target Values for 25-Hydroxy and 1,25-Dihydroxy Vitamin D Based on Their Associations with Inflammation and Calcium-Phosphate Metabolism.基于与炎症和钙磷代谢的相关性设定 25-羟维生素 D 和 1,25-二羟维生素 D 的目标值。
Nutrients. 2024 Aug 13;16(16):2679. doi: 10.3390/nu16162679.
4
Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study.维生素 D 与疣风险的关联:一项回顾性和孟德尔随机化研究。
Skin Res Technol. 2024 Aug;30(8):e13911. doi: 10.1111/srt.13911.
5
Association between serum 25-hydroxyvitamin D and vitamin D dietary supplementation and risk of all-cause and cardiovascular mortality among adults with hypertension.血清 25-羟维生素 D 与维生素 D 膳食补充剂与高血压成年人全因和心血管死亡率的关系。
Nutr J. 2024 Mar 9;23(1):33. doi: 10.1186/s12937-024-00914-8.
6
Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 µg) of Vitamin D for Adults in the General Population.维生素 D 补充:每日补充 2000 国际单位(50μg)维生素 D 以满足一般人群中成年人需求的证据综述。
Nutrients. 2024 Jan 29;16(3):391. doi: 10.3390/nu16030391.
7
Controlling Chronic Diseases and Acute Infections with Vitamin D Sufficiency.用维生素 D 充足来控制慢性疾病和急性感染。
Nutrients. 2023 Aug 18;15(16):3623. doi: 10.3390/nu15163623.
8
Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate.关于维生素D可耐受最高摄入量的科学意见,包括单水骨化二醇换算因子的推导。
EFSA J. 2023 Aug 8;21(8):e08145. doi: 10.2903/j.efsa.2023.8145. eCollection 2023 Aug.
9
Adequate vitamin D level associated with reduced risk of sporadic colorectal cancer.充足的维生素D水平与散发性结直肠癌风险降低相关。
Front Nutr. 2023 Jan 26;10:1024849. doi: 10.3389/fnut.2023.1024849. eCollection 2023.
10
Vitamin D in Cancer Prevention: Gaps in Current Knowledge and Room for Hope.维生素 D 在癌症预防中的作用:当前知识空白与希望空间。
Nutrients. 2022 Oct 27;14(21):4512. doi: 10.3390/nu14214512.

本文引用的文献

1
A Method-bridging Study for Serum 25-hydroxyvitamin D to Standardize Historical Radioimmunoassay Data to Liquid Chromatography-Tandem Mass Spectrometry.一项血清25-羟基维生素D的方法桥接研究,用于将历史放射免疫分析数据标准化为液相色谱-串联质谱法数据。
Natl Health Stat Report. 2016 Apr 25(93):1-16.
2
Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey.对加拿大健康测量调查中的25-羟基维生素D值进行标准化。
Am J Clin Nutr. 2015 Nov;102(5):1044-50. doi: 10.3945/ajcn.114.103689. Epub 2015 Sep 30.
3
Developing vitamin D dietary guidelines and the lack of 25-hydroxyvitamin D assay standardization: The ever-present past.制定维生素D膳食指南及25-羟基维生素D检测缺乏标准化:一直存在的过去。
J Steroid Biochem Mol Biol. 2016 Nov;164:115-119. doi: 10.1016/j.jsbmb.2015.08.027. Epub 2015 Aug 28.
4
Standardizing serum 25-hydroxyvitamin D data from four Nordic population samples using the Vitamin D Standardization Program protocols: Shedding new light on vitamin D status in Nordic individuals.使用维生素D标准化计划方案对来自四个北欧人群样本的血清25-羟基维生素D数据进行标准化:为北欧个体的维生素D状况提供新线索。
Scand J Clin Lab Invest. 2015 Nov;75(7):549-61. doi: 10.3109/00365513.2015.1057898.
5
Thresholds for Serum 25(OH)D Concentrations With Respect to Different Outcomes.血清25(OH)D浓度相对于不同结局的阈值。
J Clin Endocrinol Metab. 2015 Jun;100(6):2480-8. doi: 10.1210/jc.2015-1353. Epub 2015 Apr 9.
6
Significance of serum 24,25-dihydroxyvitamin D in the assessment of vitamin D status: a double-edged sword?血清24,25-二羟基维生素D在评估维生素D状态中的意义:一把双刃剑?
Clin Chem. 2015 Apr;61(4):636-45. doi: 10.1373/clinchem.2014.234955. Epub 2015 Feb 20.
7
Standardizing vitamin D assays: the way forward.维生素D检测标准化:前进的道路。
J Bone Miner Res. 2014 Aug;29(8):1709-14. doi: 10.1002/jbmr.2252.
8
Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES.25-羟维生素 D 与全因死亡率之间是否存在反向 J 型关联?来自美国具有全国代表性的 NHANES 的结果。
J Clin Endocrinol Metab. 2013 Jul;98(7):3001-9. doi: 10.1210/jc.2013-1333. Epub 2013 May 10.
9
Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys.评估维生素 D 标准化计划方案用于标准化血清 25-羟维生素 D 数据的效果:以该方案应用于国家营养与健康调查为例。
Am J Clin Nutr. 2013 Jun;97(6):1235-42. doi: 10.3945/ajcn.112.057182. Epub 2013 Apr 24.
10
A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study.一般实践中全因死亡率与血清 25-羟维生素 D 的反向 J 型关联:CopD 研究。
J Clin Endocrinol Metab. 2012 Aug;97(8):2644-52. doi: 10.1210/jc.2012-1176. Epub 2012 May 9.

血清总25-羟基维生素D浓度与全因死亡率之间的反向J形关联:检测标准化的影响。

The Reverse J-Shaped Association Between Serum Total 25-Hydroxyvitamin D Concentration and All-Cause Mortality: The Impact of Assay Standardization.

作者信息

Durazo-Arvizu Ramón A, Dawson-Hughes Bess, Kramer Holly, Cao Guichan, Merkel Joyce, Coates Paul M, Sempos Christopher T

出版信息

Am J Epidemiol. 2017 Apr 15;185(8):720-726. doi: 10.1093/aje/kww244.

DOI:10.1093/aje/kww244
PMID:28338905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5394249/
Abstract

We evaluated the impact of standardizing the originally measured serum total 25-hydroxyvitamin D (25(OH)D) values from Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994) on the association between 25(OH)D and rate of all-cause mortality. Values were standardized to the gold-standard laboratory method. Follow-up from 1990-2006 consisted of 15,099 participants aged at least 20 years at baseline, among whom there were 3,784 deaths. Relative risk of death was adjusted for age, sex, race/ethnicity, and season using Poisson regression. Results were obtained for eight 25(OH)D (nmol/L) categories: <20 nmol/L, 20-29 nmol/L, 30-39 nmol/L, 40-49 nmol/L, 50-59 nmol/L, 60-74 nmol/L, 75-99 nmol/L (reference), and ≥100 nmol/L. Assay standardization dramatically shifted original 25(OH)D values toward zero. Accordingly, risk ≥120 nmol/L could not be evaluated (i.e., n = 7 and ndeaths = 2). Relative risk (95% confidence interval (CI)) <40 nmol/L remained significant (30-39 nmol/L: relative risk (RR) = 1.4 (95% CI: 1.1, 1.6); 20-29 nmol/L: RR = 1.6 (95% CI: 1.3, 1.9), and <20 nmol/L: RR = 2.1 (95% CI: 1.6, 2.7). However, adjusted relative risk estimates for 25(OH)D levels ≥40 nmol/L were no longer significant (40-49 nmol/L: RR = 1.2 (95% CI: 0.99, 1.4); 50-59 nmol/L: RR = 1.2 (95% CI: 1.04, 1.4); 60-74 nmol/L: RR = 1.1 (95% CI: 0.94, 1.2); 75-99 nmol/L: RR = 1.0 (referent), and ≥100 nmol/L: RR = 1.1 (95% CI: 0.6, 2.1). In summary, after standardization, risk of death from all causes increased with decreasing 25(OH)D <40 nmol/L, while there was no association with values in categories between 40 nmol/L and 120 nmol/L.

摘要

我们评估了对第三次全国健康与营养检查调查(NHANES III,1988 - 1994年)中最初测量的血清总25 - 羟基维生素D(25(OH)D)值进行标准化,对25(OH)D与全因死亡率之间关联的影响。将这些值按照金标准实验室方法进行标准化。1990年至2006年的随访包括15099名基线年龄至少20岁的参与者,其中有3784人死亡。使用泊松回归对死亡相对风险进行年龄、性别、种族/族裔和季节的校正。针对八个25(OH)D(nmol/L)类别得出结果:<20 nmol/L、20 - 29 nmol/L、30 - 39 nmol/L、40 - 49 nmol/L、50 - 59 nmol/L、60 - 74 nmol/L、75 - 99 nmol/L(参考值)和≥100 nmol/L。检测标准化使原始25(OH)D值大幅向零偏移。因此,无法评估≥120 nmol/L的风险(即,n = 7且ndeaths = 2)。<40 nmol/L的相对风险(95%置信区间(CI))仍然显著(30 - 39 nmol/L:相对风险(RR)= 1.4(95% CI:1.1,1.6);20 - 29 nmol/L:RR = 1.6(95% CI:1.3,1.9),以及<20 nmol/L:RR = 2.1(95% CI:1.6,2.7)。然而,25(OH)D水平≥40 nmol/L的校正相对风险估计不再显著(40 - 49 nmol/L:RR = 1.2(95% CI:0.99,1.4);50 - 59 nmol/L:RR = 1.2(95% CI:1.04,1.4);60 - 74 nmol/L:RR = 1.1(95% CI:0.94,1.2);75 - 99 nmol/L:RR = 1.0(参考值),以及≥100 nmol/L:RR = 1.1(95% CI:0.6,2.1)。总之,标准化后,25(OH)D<40 nmol/L时全因死亡风险随其降低而增加,而40 nmol/L至120 nmol/L各类别值之间无关联。